Rwanda's national ART guidelines [36] recommend initiating antiretroviral treatment for all individuals with CD4<350 cells/μl (regardless of AIDS symptoms), as well as for those in the most advanced clinical disease stage (regardless of CD4 count). Here, CD4 is linked to AIDS.